8-K 1 htm_55544.htm LIVE FILING Innospec Inc. (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   November 7, 2017

Innospec Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 1-13879 98-0181725
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
8310 South Valley Highway, Suite 350, Englewood, Colorado   CO 80112
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   (303) 792 5554

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]


Item 2.02 Results of Operations and Financial Condition.

On November 7, 2017, Innospec Inc. (the "Company") issued a press release (the "Press Release") announcing its financial results for the quarter ended September 30, 2017.





Item 7.01 Regulation FD Disclosure.

The Press Release also announced that on November 3, 2017, the Company's Board of Directors declared a semi-annual dividend of $0.39 per share on the Company's common stock (IOSP). The dividend will be paid on November 27, 2017, to holders of record on November 16, 2017





Item 9.01 Financial Statements and Exhibits.

A copy of the Press Release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.





In accordance with General Instruction B.2 to the Form 8-K, the information under Items 2.02 and 7.01 and the Press Release Exhibit to this Form 8-K shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section 18, nor shall such information and Exhibit be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the "Securities Act"), unless the Company expressly states that such information and Exhibit are to be considered "filed" under the Exchange Act or incorporates such information and Exhibit by specific reference in an Exchange Act or Securities Act filing.


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press Release announcing the financial results for the quarter ended September 30, 2017


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Innospec Inc.
          
November 7, 2017   By:   David E. Williams
       
        Name: David E. Williams
        Title: VP, General Counsel, CCO and Corporate Secretary